GRIFFITHS-JONES; Charlotte Mary
Patent Applications and Registrations
Patent applications and USPTO patent grants for GRIFFITHS-JONES; Charlotte Mary.The latest application filed is for "bicyclic heterocycle compounds and their uses in therapy".
Company Profile
13.23.29
- GRIFFITHS-JONES; Charlotte Mary - Cambridge GB
- GRIFFITHS-JONES; Charlotte Mary - Cambridgeshire GB
- GRIFFITHS-JONES; Charlotte Mary - Cambridge State: GB
- Griffiths-Jones; Charlotte Mary - Chambridge GB
Patent Activity
| Patent | Date |
|---|---|
| Bicyclic Heterocycle Compounds And Their Uses In Therapy App 20220204503 - CHESSARI; Gianni ; et al. | 2022-06-30 |
| Ether Linked Triazoles As Nrf2 Activators App 20220089590 - Cooper; Anthony William James ; et al. | 2022-03-24 |
| Bicyclic heterocycle compounds and their uses in therapy Grant 11,225,476 - Chessari , et al. January 18, 2 | 2022-01-18 |
| Ether linked triazoles as NRF2 activators Grant 11,059,816 - Cooper , et al. July 13, 2 | 2021-07-13 |
| Benzolactam compounds as protein kinase inhibitors Grant 11,001,575 - Berdini , et al. May 11, 2 | 2021-05-11 |
| Bicyclic Heterocycle Compounds And Their Uses In Therapy App 20210122749 - WOOLFORD; Alison Jo-Anne ; et al. | 2021-04-29 |
| Isoindolinone Inhibitors Of The Mdm2-p53 Interaction And Process For Making Them App 20210101887 - HOWARD; Steven ; et al. | 2021-04-08 |
| Bicyclic Heterocycle Compounds And Their Uses In Therapy App 20200325134 - CHESSARI; Gianni ; et al. | 2020-10-15 |
| Bicyclic heterocycle compounds and their uses in therapy Grant 10,618,895 - Chessari , et al. | 2020-04-14 |
| Nrf2 REGULATORS App 20200079759 - KERNS; Jeffrey K. ; et al. | 2020-03-12 |
| N-aryl Pyrazoles As Nrf2 Regulators App 20200071310 - BUDZIK; Brian W. ; et al. | 2020-03-05 |
| Ether Linked Triazoles As Nrf2 Activators App 20200071317 - COOPER; Anthony William James ; et al. | 2020-03-05 |
| Bicyclic Heterocycle Compounds And Their Uses In Therapy App 20190375748 - WOOLFORD; Alison Jo-Anne ; et al. | 2019-12-12 |
| Benzolactam compounds as protein kinase inhibitors Grant 10,457,669 - Berdini , et al. Oc | 2019-10-29 |
| Biaryl pyrazoles as NRF2 regulators Grant 10,364,256 - Callahan , et al. | 2019-07-30 |
| Arylcyclohexyl pyrazoles as NRF2 regulators Grant 10,351,530 - Callahan , et al. July 16, 2 | 2019-07-16 |
| Benzolactam Compounds As Protein Kinase Inhibitors App 20190047990 - BERDINI; Valerio ; et al. | 2019-02-14 |
| NRF2 Regulators App 20190002454 - BOEHM; Jeffrey Charles ; et al. | 2019-01-03 |
| Arylcyclohexyl Pyrazoles As Nrf2 Regulators App 20180282283 - CALLAHAN; James ; et al. | 2018-10-04 |
| Biaryl Pyrazoles As Nrf2 Regulators App 20180282349 - CALLAHAN; James ; et al. | 2018-10-04 |
| Nrf2 REGULATORS App 20180179187 - KERNS; Jeffrey K. ; et al. | 2018-06-28 |
| Nrf2 REGULATORS App 20180179167 - KERNS; Jeffrey K. ; et al. | 2018-06-28 |
| Bicyclic Heterocycle Compounds And Their Uses In Therapy App 20180065959 - CHESSARI; Gianni ; et al. | 2018-03-08 |
| Bicyclic Heterocycle Compounds And Their Uses In Therapy App 20170334907 - WOOLFORD; Alison Jo-Anne ; et al. | 2017-11-23 |
| Bicyclic heterocycle compounds and their uses in therapy Grant 9,783,538 - Chessari , et al. October 10, 2 | 2017-10-10 |
| Bicyclic heterocycle compounds and their uses in therapy Grant 9,676,768 - Woolford , et al. June 13, 2 | 2017-06-13 |
| Bicyclic Heterocycle Compounds And Their Uses In Therapy App 20170029419 - CHESSARI; Gianni ; et al. | 2017-02-02 |
| Nrf2 Regulators App 20160318917 - Boehm; Jeffrey Charles ; et al. | 2016-11-03 |
| Bicyclic Heterocycle Compounds And Their Uses In Therapy App 20150291586 - WOOLFORD; Alison Jo-Anne ; et al. | 2015-10-15 |
| Bicyclic heterocycle compounds and their uses in therapy Grant 9,018,214 - Woolford , et al. April 28, 2 | 2015-04-28 |
| Bicyclic heterocyclic compounds as FGFR inhibitors Grant 8,895,745 - Berdini , et al. November 25, 2 | 2014-11-25 |
| Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors Grant 8,859,582 - Saxty , et al. October 14, 2 | 2014-10-14 |
| Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors Grant 8,859,583 - Saxty , et al. October 14, 2 | 2014-10-14 |
| Imidazopyridine derivatives as inhibitors of receptor tyrosine kinases Grant 8,796,244 - Berdini , et al. August 5, 2 | 2014-08-05 |
| Bicyclic Heterocycle Compounds And Their Uses In Therapy App 20140179666 - Woolford; Alison Jo-Anne ; et al. | 2014-06-26 |
| Imidazo[1,2-a]pyridine compounds for use in treating cancer Grant 8,513,276 - Berdini , et al. August 20, 2 | 2013-08-20 |
| Imidazopyridine Derivatives As Inhibitors Of Receptor Tyrosine Kinases App 20120208791 - Berdini; Valerio ; et al. | 2012-08-16 |
| Bicyclic Heterocyclic Compounds As Protein Tyrosine Kinase Inhibitors App 20120035152 - SAXTY; Gordon ; et al. | 2012-02-09 |
| Bicyclic Heterocyclic Compounds As Protein Tyrosine Kinase Inhibitors App 20120035153 - SAXTY; Gordon ; et al. | 2012-02-09 |
| Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors Grant 8,076,354 - Saxty , et al. December 13, 2 | 2011-12-13 |
| Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors Grant 8,071,614 - Saxty , et al. December 6, 2 | 2011-12-06 |
| Bicyclic Heterocyclic Compounds As Protein Tyrosine Kinase Inhibitors App 20100331296 - Saxty; Gordon ; et al. | 2010-12-30 |
| Bicyclic Heterocyclic Compounds As Protein Tyrosine Kinase Inhibitors App 20100286113 - Saxty; Gordon ; et al. | 2010-11-11 |
| Bicyclic Heterocyclic Compounds as FGFR Inhibitors App 20100120761 - Berdini; Valerio ; et al. | 2010-05-13 |
| Compounds App 20100093718 - Berdini; Valerio ; et al. | 2010-04-15 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 